Canada's new drug price rules pushed to next year

New York Times

1 June 2020 - Canada's drug pricing agency said on Monday that new regulations aimed at lowering costs would come into force in January next year instead of next month after receiving extensive feedback on its proposed rules.

Canada in August proposed the new regulations under patent protection despite heavy lobbying from drugmakers that stand to lose billions in revenue.

The new rules base Canadian drug prices on those from a group of countries with lower prices than the benchmark group currently used to set price ceilings and give regulators the power to review new medicines based on cost effectiveness.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada